English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Tools annual

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Presents the access of premium content as premium feature

Premium Content

Global: Zendy Plus annual

Global: Zendy Free Plan

Pigs were identified as potential test pigs at birth and ear tagged for identification. Characteristics including litter, genetic background, gender, and birth weight were recorded and used in allotting PCV2 vaccine treatment groups. Pigs were vaccinated according to label dose with a 2-dose commercial PCV2 vaccine (Circumvent PCV, Intervet Inc., Millsboro, DE) at weaning (d 0) and again 14 d later. Vaccinated and control pigs were comingled within the same pen for the duration of the study. Pigs were individually weighed on d 0, 40, and 130 to measure growth rate. Backfat and loin depth were measured on d 130 by using real-time ultrasound. Blood was collected on d 0, 40, and 130 for indirect fluorescent antibody measurement of PCV2 antibodies and polymerase chain reaction (PCR) analysis for determination of PCV2 virus load. By d 130, vaccinates were heavier (P < 0.01) than controls. However, the magnitude of the weight difference between control and vaccinates was almost 4 times greater in the A×A pigs than in the B×B pigs (P < 0.05). On the basis of growth performance, the different genetic backgrounds responded differently to the PCV2 vaccination even though they were comingled in the same pen. In the 2 pure-line populations, even the best performing portion of the population appeared to benefit from vaccination, suggesting that growth performance of most pigs is being affected by PCV2 infection.

Genetic background influences pig growth rate responses to porcine circovirus type 2 (pcv2) vaccines